Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial
about
Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversiesModern diagnosis of Trichomonas vaginalis infectionTrichomoniasis - are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide?Point of care diagnostics for sexually transmitted infections: perspectives and advancesThe role of physical examination in diagnosing common causes of vaginitis: a prospective study.Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay.Female epidemiology of transcription-mediated amplification-based Trichomonas vaginalis detection in a metropolitan setting with a high prevalence of sexually transmitted infectionTrichomoniasis: the "neglected" sexually transmitted disease.United Kingdom National Guideline on the Management of Trichomonas vaginalis 2014.Sexually transmitted diseases treatment guidelines, 2015.The epidemiology of sexually transmitted co-infections in HIV-positive and HIV-negative African-Caribbean women in Toronto.Trichomonas vaginalis infection among young pregnant women in Brazil.Self-administered sample collection for screening of sexually transmitted infection among reservation-based American Indian youth.Three-year history of transcription-mediated amplification-based Trichomonas vaginalis analyte-specific reagent testing in a subacute care patient population.Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care.A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis InfectionsTrichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalenceScreening of male patients for Trichomonas vaginalis with transcription-mediated amplification in a community with a high prevalence of sexually transmitted infection.Clinical Laboratory Assessment of Mycoplasma genitalium Transcription-Mediated Amplification Using Primary Female Urogenital Specimens.The Presentation, Diagnosis, and Treatment of Sexually Transmitted InfectionsClinical evidence for the role of Trichomonas vaginalis in regulation of secretory leukocyte protease inhibitor in the female genital tract.Comparison of self-obtained penile-meatal swabs to urine for the detection of C. trachomatis, N. gonorrhoeae and T. vaginalis.A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women.The incidence of Trichomonas vaginalis infection in women attending nine sexually transmitted diseases clinics in the USA.Rapid Diagnosis of Trichomonas vaginalis by Testing Vaginal Swabs in an Isothermal Helicase-Dependent AmpliVue AssayCorrelation of leukorrhea and Trichomonas vaginalis infection.Trichomonas vaginalis infection in men who submit self-collected penile swabs after internet recruitment.Diagnostic rates differ on the basis of the number of read days with the use of the InPouch culture system for Trichomonas vaginalis screening.Cross-sectional study to evaluate Trichomonas vaginalis positivity in women tested for Neisseria gonorrhoeae and Chlamydia trachomatis, attending genitourinary medicine and primary care clinics in Bristol, South West England.Strategies for Prevention and Treatment of Trichomonas vaginalis Infections.Sexual Assault and Sexually Transmitted Infections in Adults, Adolescents, and Children.A Scottish multi-centre service evaluation examining the prevalence and diagnosis of Trichomonas vaginalis in symptomatic women attending sexual health clinics.Distribution and risk factors of Trichomonas vaginalis infection in England: an epidemiological study using electronic health records from sexually transmitted infection clinics, 2009-2011.Trichomonas vaginalis infection among women receiving gynaecological care at an Alabama HIV Clinic.The clinical spectrum of Trichomonas vaginalis infection and challenges to management.Insights into trichomoniasis as a result of highly sensitive molecular diagnostics screening in a high-prevalence sexually transmitted infection community.Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.Trichomonas vaginalis: Clinical relevance, pathogenicity and diagnosis.Trichomonas vaginalis: An Updated Overview Towards Diagnostic Improvement.
P2860
Q26822674-64129561-C18B-4A0B-895C-B0C1CC2EAB97Q26822739-35AC27AC-3506-43AB-8D5D-B544C41900AEQ30235029-B265E435-0561-4A76-B67E-E81BF625E04FQ30436304-BE12DE27-7084-42A7-BC12-27ECAD3E5092Q33926098-2745A5B5-75E1-4B81-89D0-938B2D42B196Q34276878-A5034FB3-69B8-48AF-9D0E-2A2D5567A4A8Q34302176-CBCDA8F7-2AEB-42F8-B8A0-FE4865CE9E50Q34387759-2C409756-239E-4CA3-90F4-8486C9D82A62Q34409461-952E6838-5ADA-454D-9BD8-6CBF45FD4C34Q34479272-BBB58344-D418-4D95-83C1-C6F7ABB23651Q35044610-26FAE510-56B2-4677-93E7-B556777EB69BQ35230113-DDD6FD1F-6A27-40CE-A489-2632761B5905Q35243753-8759EFE7-0AA6-4A86-BA10-E5FD2CB13A75Q35598935-CE89E33C-BC83-4A88-8EA2-AD4EED42E7EAQ36180027-4D868018-4CC5-443C-A80F-813D0E9BE1F5Q36311615-37D48552-1C7F-4882-A8A1-7CD135BA5793Q36368342-69DAA52D-2D56-4B44-B609-CCF16F33FDBDQ36506408-08171904-8C7F-4B9E-B071-64899047E0CBQ36521297-F0816AC8-FFF7-4E4F-8F00-462BD8A33B6BQ36559353-6E50E754-50C1-4D1B-A89B-C5A38D3573C0Q36723344-58C502D7-4A52-4C9F-AA7E-BD2013684576Q36900776-E7CD8CF4-8B37-4198-B802-6984E488ECEFQ36912247-48557566-903C-4DA5-956F-68F059082DF4Q36921492-1BC82A2A-E868-46AC-88A9-D1577B911C49Q36921621-FB7C4908-DC47-4DB1-95EE-E3CD900E11B6Q36970987-025C89A0-504C-49F0-ACD7-268D0F61D529Q37107242-C3CF016C-0D05-4621-89E9-102B0757338EQ37470521-D8459C7E-80FD-41E3-BE64-CF617D7159D4Q37833668-B5EDD9A4-BA71-43C1-9FB5-523C19D54099Q37834095-9B9F29EA-1B1D-477F-A578-AC61F67738AEQ37838425-3C1B4B7D-F309-4859-BAC4-2C164AF90695Q37838869-2CC82F7E-A732-46F6-967F-2C387AE82C37Q37845447-949E0B00-99C7-449F-BC4E-208E74E7BC21Q38085531-454FE73D-3310-49CD-A2DC-48B0D5670662Q38094639-3E9AC4C6-598D-4955-8533-1EE18262C9D2Q38128845-E7B6217E-5FD8-4927-80DA-3EF991778CD5Q38189822-9E4CA7D8-6333-4BC6-BED3-62DC27FFE5A5Q38220128-72CD037A-34A8-4B1E-B3AB-9B5242918F71Q38266507-D290CBDC-2AF1-41A7-8DAB-4962D41F73E9Q38692172-0B887A54-F0D7-46B1-8B18-3469F112F1CB
P2860
Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Molecular testing for Trichomo ...... rospective U.S. clinical trial
@ast
Molecular testing for Trichomo ...... rospective U.S. clinical trial
@en
type
label
Molecular testing for Trichomo ...... rospective U.S. clinical trial
@ast
Molecular testing for Trichomo ...... rospective U.S. clinical trial
@en
prefLabel
Molecular testing for Trichomo ...... rospective U.S. clinical trial
@ast
Molecular testing for Trichomo ...... rospective U.S. clinical trial
@en
P2093
P2860
P356
P1476
Molecular testing for Trichomo ...... rospective U.S. clinical trial
@en
P2093
Ann D Johnson
Arlene C Sena
Barbara S Weinbaum
Charlotte A Gaydos
Damon K Getman
Jane R Schwebke
Marcia M Hobbs
Michael G Catania
Stephanie N Taylor
P2860
P304
P356
10.1128/JCM.01291-11
P407
P577
2011-09-21T00:00:00Z